Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018.
Samuel CoenenAlike W van der VeldenDaniela CianciHerman GoossensEmily BongardBenjamin R SavilleNina GobatMuireann de PaorMargareta IevenTheo J VerheijChristopher C ButlerPublished in: The British journal of general practice : the journal of the Royal College of General Practitioners (2020)
Primary care patients with ILI testing positive for coronavirus (not including SARS-CoV-2) recovered sooner when oseltamivir was added to usual care compared with usual care alone. This may be of relevance to the primary care management of COVID-19.